Effective control of both cell survival and cell proliferation is critical to the prevention of oncogenesis and to successful cancer therapy. Using functional expression cloning, we have identified GAS5 (growth arrest-specific transcript 5) as critical to the control of mammalian apoptosis and cell population growth. GAS5 transcripts are subject to complex post-transcriptional processing and some, but not all, GAS5 transcripts sensitize mammalian cells to apoptosis inducers. We have found that, in some cell lines, GAS5 expression induces growth arrest and apoptosis independently of other stimuli. GAS5 transcript levels were significantly reduced in breast cancer samples relative to adjacent unaffected normal breast epithelial tissues. The GAS5 gene has no significant protein-coding potential but expression encodes small nucleolar RNAs (snoRNAs) in its introns. Taken together with the recent demonstration of tumor suppressor characteristics in the related snoRNA U50, our observations suggest that such snoRNAs form a novel family of genes controlling oncogenesis and sensitivity to therapy in cancer.
Introduction
Ever since the word apoptosis was coined and the concept defined (Kerr et al., 1972) , the importance of this process, or rather the lack of it, in cancer, has been clear (Kerr et al., 1994) . As it is now generally accepted that apoptosis plays an essential role in many physiological processes, from cell turnover in most tissues to the removal of hormone-dependent cells (Warri et al., 1993; Hale et al., 1996; Hengartner, 2000) , failure of apoptosis is inevitably of great significance. Mutations or other dysregulation of genes controlling apoptosis are therefore crucial in oncogenesis (Williams and Smith, 1993; Green and Evan, 2002) , and, as many conventional cytotoxic therapies induce apoptosis (Chinnaiyan et al., 2000; Mackeigan et al., 2000) , apoptosis failure is highly significant in the development of the therapyresistant cancer cells that produce many of the obstacles to the complete elimination of cancers (Johnstone et al., 2002) .
Many of the oncogenes and tumor suppressors already identified act, at least in part, through affecting apoptosis. Bcl-2, for example, acts primarily through the suppression of apoptosis (Vaux et al., 1988; Williams et al., 1990) , and stimulation of apoptosis by p53 is an important part of its tumor suppressor activity (Lowe et al., 1993; Sax et al., 2002) . These clear precedents for the involvement of apoptosis dysfunction in cancer provide a powerful stimulus for the identification of further apoptosis-controlling genes, as these too may play significant roles in cancer.
Functional expression cloning has provided a notably powerful strategy for identifying genes that control the most fundamental decision made by the cell-whether to live or to die-by utilizing the effect of the gene itself on cell death and survival (Deiss et al., 1995; Inbal et al., 1997; Bialik and Kimchi, 2006) . The key advantage of this strategy is that it identifies those genes that play a causal role in the cell death process, and distinguishes this crucial group of genes from those that are differentially expressed but do not affect the cell death/survival decision (Sutherland et al., 2000; Mourtada-Maarabouni et al., 2002 , 2003a , b, 2004 , 2005 Williams et al., 2006 ; reviewed in Williams and Farzaneh, 2004) .
GAS5 (growth arrest-specific transcript 5) was originally isolated from NIH 3T3 cells using subtraction hybridization (Schneider et al., 1988) . Subsequent studies showed that GAS5 transcripts displayed many different patterns of alternate splicing but that the putative open reading frame (ORF) was small and poorly conserved during even relatively short periods of evolution (Muller et al., 1998; Raho et al., 2000) . It has therefore been deduced that any important biological activity of GAS5 must be mediated through the introns, which encode multiple small nucleolar RNAs (snoRNAs; Smith and Steitz, 1998) .
Here we show that overexpression of certain GAS5 transcripts induces growth arrest and apoptosis in several mammalian cell lines, including human breast cancer cell lines. We also show that GAS5 expression is significantly downregulated in breast cancer cells, suggesting that a decrease in expression levels may be significant in oncogenesis. The recent observations that the GAS5 gene becomes fused to the BCL6 gene in a B-cell lymphoma (Nakamura et al., 2008) and that mutation in the related snoRNA U50 is associated with clinically significant prostate cancer (Dong et al., 2008) indicate that these non-protein-coding snoRNAs play a widespread but previously unsuspected role in the development and therapy of cancer.
Results
Overexpression of Gas5 enhances stimulation of W7.2c cell apoptosis by UV and dexamethasone The apoptosis-sensitive W7.2c mouse thymoma cell subclone (Danielsen et al., 1983; Mourtada-Maarabouni et al., 2003a) was originally the host cell for isolation of a partial sequence of Gas5 in the functional screen for genes controlling apoptosis . We therefore examined the effects of expression of a Gas5 expressed sequence tag (EST) in this cell line. W7.2c cells were transiently transfected with the expression vector pCMVSPORT6 or pCMVSPORT6 with mouse Gas5 (IMAGE clone 3585621; transfection efficiency was 60-70%). After 24 h, cells were exposed to ultraviolet (UVC) irradiation (40 J/m 2 ) or dexamethasone (60 nM). Cell viability was determined after 48 h by nigrosin exclusion analysis, apoptosis was also determined after 48 h and long-term survival was assessed by colonyforming assays. Expression of Gas5 was assessed using real-time reverse transcriptase PCR (RT-PCR) (assay ID Mm 00657322; exon boundary 6-7) and an average fourfold increase in Gas5 was detected in cells transfected with Gas5 as compared with cells transfected with vector alone (Figure 1a ). The rate of proliferation of Gas5-transfected cells was not significantly different from that of control cells (Figure 1b ), but the cells were more sensitive to UV and dexamethasone (Figures 1c  and d) , indicating that the overexpression of Gas5 enhances UV-and dexamethasone-induced apoptosis. Colony-forming assays also confirmed the ability of Gas5 to enhance cell death caused by UV and dexamethasone, as cells transfected with Gas5 formed many fewer colonies after UV or dexamethasone exposure relative to cells transfected with vector alone (Figure 1e ).
Overexpression of human GAS5 in human adherent cell lines
We examined the effect of induced expression of one GAS5 splice variant, GAS5-01 (IMAGE clone 5739605), on cell proliferation and apoptosis in breast cancer cell lines MCF-10A and MCF-7 and in human embryonic kidney 293T (HEK 293T) cells. These human adherent cell lines were transfected with pCMVSPORT6-GAS5-01 or the vector pcMVSPORT6 alone (transfection efficiency 70-85%). Real-time RT-PCR revealed that GAS5 expression was 4-to 6-fold increase in the GAS5-01-transfected cells as compared with the parental cells (Figure 2 ). GAS5 expression was not changed in cells transfected with vector alone.
Effects of overexpression of human GAS5 on human adherent cells: MCF-10A As for W7.2c cells, overexpression of GAS5-01 did not significantly affect MCF-10A cell growth ( Figure 3a) . As GAS5 is subject to complex post-transcriptional processing, we also examined the effects of overexpression of four other (potentially partially processed) GAS5 ESTs. None of the ESTs affected MCF-10A proliferation significantly (Figure 3a) . However, as for W7.2c cells, overexpression of GAS5-01 sensitized MCF-10A cells to UV-and cisplatin-induced apoptosis. After UV irradiation, for example, GAS5-01-transfected MCF-10A cells exhibited reduced viability ( Figure 3b ) and increased apoptosis (Figure 3c ) as compared with vector-transfected and parental cells. Similarly, the colony-forming ability of GAS5-01-expressing cells was greatly reduced compared with that of vectortransfected or parental cells ( Figure 3d ). As GAS5-01 overexpression sensitized MCF-10A to UV-induced apoptosis (Figures 3d and e) , we also investigated whether GAS5-01 affected apoptosis induced by cisplatin (10 mg/ml), okadaic acid (30 nM) and doxorubicin 1 mg/ml). Cells transfected with GAS5-01 were also significantly more sensitive to these apoptotic stimuli over extended dose ranges (Figures 3f-h ), indicating that overexpression of GAS5-01 in MCF-10A enhances apoptosis mediated by a range of apoptosis stimuli.
Effects of overexpression of human GAS5 on human adherent cells: MCF-7 MCF-7 cells transfected with pCMVSPORT6-GAS5-01 or pCMVSPORT6 alone were grown for 5 days and their proliferation was monitored using the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)) assay. In contrast to its effects on MCF-10A, GAS5 overexpression caused a significant inhibition of the growth of MCF-7 cells in culture (Figure 4a ). Similar inhibition was seen on the transfection of ESTs GAS5-2B and GAS5-3A, whereas the ESTs GAS5-1B and GAS5-4A had no effect. The inhibition of growth was accompanied by a corresponding increase in the rate of apoptosis (Figure 4b ). This effect was not dependent on the presence of the GAS5 ORF, as this is not included in GAS5-2B (MourtadaMaarabouni et al., 2008) . The importance of GAS5-01 in regulating apoptosis in MCF-7 was also determined by exposing pCMVSPORT6-and pCMVSPORT6-GAS5-01-transfected cells either to UV irradiation (40 J/m 2 ) or cisplatin (10 mg/ml). Cell viability and apoptosis were determined after 48 h, and colonyforming assays were also set up at this time. GAS5-01-transfected cells were more sensitive to UV-and cisplatin-induced apoptosis, and the number of viable cells was substantially reduced in this population As MCF-7 cells do not express caspase 3 (Li et al., 1997), we used caspase-8 and caspase-9 inhibitors to examine the caspase dependency of apoptosis induction by the different GAS5 transcripts (Figure 4f ). Treatment with the caspase-9 inhibitor (on the basis of the proteolytic target peptide sequence LEHD) did not produce significant inhibition of apoptosis induction by any of the GAS5 transcripts (Figures 4g and h ). The caspase-8 inhibitor (on the basis of the proteolytic target peptide sequence IETD) produced significant inhibition of the apoptosis induced by the GAS5-01 and GAS5-3A transcripts (Figures 4g and h ), although, particularly in the case of GAS5-3A, the protective effect was partial. It was notable that the apoptosis induced by the GAS5-2B transcript was not significantly inhibited by either the caspase-8 inhibitor or the caspase-9 inhibitor (Figures 4g and h ).
Effects of overexpression of human GAS5 on human adherent cells: 293T cells HEK 293T cells were transfected with expression constructs containing GAS5-01 and GAS5-4 other GAS5 ESTs and their effects on cell growth were monitored ( Figure 5a ). Only GAS5-01 affected HEK 293T cell growth significantly ( Figure 5a ). GAS5-01-transfected HEK 293T cells were substantially less viable after UV irradiation and cisplatin treatment than untransfected and vector-transfected 293T cells, based on cell counting and nigrosin staining ( Figure 5b ). In addition, the number of viable cells in the (otherwise untreated) GAS5-01-transfected cells was significantly reduced compared with the number of untransfected cells and cells transfected with pCMVSPORT6, indicating that GAS5-01 itself actively affects cell population growth. In addition, GAS5-01-transfected HEK 293T cells showed an increase in apoptotic cell number in control, UV and cisplatintreated cells as compared with untransfected and vector-transfected cells (Figure 5c ), confirming that the overexpression of GAS5-01 itself promotes apoptosis as well as enhancing UV-and cisplatin-induced apoptosis. These observations were reinforced by the colonyforming assays that revealed that GAS5-01-transfected cells produced many fewer colonies after UV and cisplatin exposure, as well as after receiving no further treatment, as compared with vector-transfected cells ( Figure 5d ). As in the case of the MCF-7 cells, the effects of these apoptosis inducers appeared approximately additive to the effects of GAS5 overexpression in HEK 293T cells.
RT-PCR analysis of GAS5 expression in HEK 293T cells HEK 293T cells were transfected with pCMVSPORT6 constructs containing GAS5-01, GAS5-1B, GAS5-2B, GAS5-3A or GAS5-4A (Mourtada- Maarabouni et al., 2008) . GAS5 expression in these cells was analysed by RT-PCR using the GAS5 forward primer located on exon 9 and the GAS5 reverse primer located on exon 12, followed by agarose gel electrophoresis of the products to confirm the overexpression of these ESTs. The presence of a 600-bp band, which corresponds to the expected size of the RT-PCR product from GAS5-1B, was observed in the cells transfected with GAS5-1B. Bands of around 750 bp, corresponding to the expected size of GAS5-2B and GAS5-4A, were found in the cells transfected with GAS5-2B and GAS5-4A, respectively (Figure 6a ). The band of 250 bp, which corresponds to the size of the expected product from GAS5-01, appeared in all the samples, but was at higher density in GAS5-01-transfected cells (Figure 6a) . A band of 450 bp, which corresponds to the expected size of GAS5-3A, was seen in the cells transfected with GAS5-3A (Figure 6a) . A band of 600 bp, which corresponds to the size of the RT-PCR product from GAS5-1B, also appeared in the vector-only lane. RT-PCR analysis of GAS5 in HEK 293T cells indicated that different GAS5 ESTs are expressed in these cells (Figure 6b ), reflecting the complexity of the processing of GAS5 transcripts.
Expression of GAS5 in prostate and breast cancer cell lines RT-PCR, using GAS5 forward and GAS5 reverse primers, was carried out on PNT2C2, P4E6, 22Rv1, LNCaP and PC3 prostate cancer cell lines, and MDA-MB-231, T47D, Hs578T, MCF-7 and MCF-10A breast cancer cell lines. All the prostate cancer cell lines expressed the single band of 250 bp, which corresponds to the GAS5-01 RT-PCR product. This band appeared most intense in the androgensensitive cell line 22Rv1 and least intense in the LNCaP and PC3 cell lines (Figure 7a ). Real-time RT-PCR was therefore carried out and the level of GAS5 expression was quantified in these cell lines relative to 22Rv1. 22Rv1, P4E6 and PNT2C2 cell lines expressed similar levels of GAS5, whereas LNCaP and PC3 expressed much lower levels of GAS5 (Figure 7b) .
A single band of 250 bp, which corresponds to the RT-PCR product from GAS5-01, was produced in all the samples from the breast cell lines. However, the intensity of this band varied greatly between the cell lines. The intensity of the 250 bp band in MCF-7, Hs578T and T47D cell lines was similar, whereas MCF-10A and MDA-MB-231 cell lines expressed a very low level of this band (Figure 7c ), relative to MCF-7. Real-time RT-PCR analysis revealed no significant difference in the GAS5 expression level between MCF-7, T47D and Hs578T cell lines, whereas the level of GAS5 expression in MCF-10A and MDA-MB-231 was significantly lower than in MCF-7 cells (Figure 7d ). GAS5 expression in breast ductal carcinoma GAS5 transcript levels were assayed in ductal carcinoma of the breast by real-time RT-PCR analysis. This study used ALAS1 as the endogenous control gene; its use being validated in a preliminary experiment in which the ALAS1/18S rRNA ratio was found to be similar (P ¼ 0.352, n ¼ 21; paired Student's t-test) in tumor and normal tissue (respective mean ± s.e.m. values were 1.62±0.36 and 1.33±0.29). Levels of GAS5 transcripts in tumor tissue, relative to ALAS1 transcripts, were reduced to 34% of those of adjacent normal tissue in the complete patient set (Figure 8a ). Similar reductions were seen for patients with stage II (31% of control level) and stage III (36% of control level) disease (Figure 8c ).
Discussion
The original identification of Gas5 from a subtraction cDNA library depended on its increased abundance in growth-arrested mouse NIH 3T3 fibroblasts (Schneider et al., 1988) . Subsequently, Gas5 was shown to be ubiquitously expressed during mouse development and adult life, and also to be expressed only at low levels in actively growing Friend leukemia and NIH 3T3 cells, with substantially increased abundance in cells grown to saturation density (Coccia et al., 1992) . Gas5 RNA levels appeared to be regulated primarily through changes in its rate of degradation rather than through changes in its transcription rate (Coccia et al., 1992; Smith and Steitz, 1998) . Gas5 RNA abundance was also increased by amino acid deprivation (Fleming et al., 1998; Fontanier-Razzaq et al., 2002) . In this study, overexpression of one or more of the GAS5 ESTs induced or facilitated apoptosis in all the cell lines examined. In the mouse thymoma W7.2c and the breast epithelial MCF-10A cell lines, overexpression of GAS5 did not induce growth arrest by itself, but did produce a clear increase in sensitivity to treatments that induce apoptosis by several different pathways (Fan et al., 1995; Lam et al., 1997; Rossini et al., 2001 ; Mourtada-Maarabouni et al., 2003a; Thomadaki and Scorilas, 2007) . For the breast epithelial MCF-7 and HEK 293T cell lines, overexpression of some GAS5 ESTs induced apoptosis without any additional stimulus (Figures 4b and 5a ). This effect is also seen in leukemic and untransformed human lymphocytes induced to overexpress GAS5 (Mourtada-Maarabouni et al., 2008) , and these studies also showed that reduction in endogenous GAS5 levels with siRNAs produces resistance to apoptosis (Mourtada-Maarabouni et al., 2008) , indicating that the effects observed are not artifacts of overexpression. There were clear differences in the caspase dependency of apoptosis induced by different GAS5 transcripts (Figures 4g and h) . Induction of MCF-7 apoptosis by GAS5-01 was markedly inhibited by the caspase-8 inhibitor, indicating involvement of the extrinsic pathway, whereas apoptosis induced by GAS5-2B was not inhibited by either the caspase-8 (acting on the extrinsic pathway) or the caspase-9 inhibitor (acting on the mitochondrial pathway). These differences, which indicate that different GAS5 transcripts stimulate apoptosis through different cellular signaling pathways, may be due to the significantly different intron/exon composition of these GAS5 transcripts, particularly the variation in the snoRNAs encoded within them (Figure 4f ). However, it was clear that not all the GAS5 ESTs induced apoptosis, even in the MCF-7 and HEK 293T cell lines. GAS5-1B and GAS5-4A did not induce apoptosis in any of the cell lines examined. GAS5-2B and GAS5-3A induced apoptosis in MCF-7 only, and GAS5-01 induced apoptosis in both MCF-7 and HEK-293T cells (Figures 4b and 5a) . Induction of apoptosis was not dependent on the presence of the ORF, as GAS5-2B does not include the ORF (MourtadaMaarabouni et al., 2008) . This lack of dependence on the ORF, which is also seen for GAS5 transcripts expressed in human T-cell lines (Mourtada-Maarabouni et al., 2008) , is consistent with GAS5 acting as a noncoding RNA (Mattick, 2005) . SnoRNAs similar to those in the GAS5 introns are involved in ribosomal RNA processing (Kiss, 2002) , and may have other, as-yet undefined functions (Matera et al., 2007) , which could account for the striking functional effects of GAS5 expression. For example, snoRNA HBII-52 regulates alternative splicing of serotonin receptor 2C (Kishore and Stamm, 2006) , and other snoRNAs help to control RNA editing (Vitali and Cavaille, 2005) .
In the prostate cell lines examined, expression levels in LNCaP and PC3 cells (derived from prostate metastases; Kaighn et al., 1979; Horoszewicz et al., 1983) were approximately one-fifth those in PNT2C2, P4E6 and 22Rv1 cells (derived from normal prostate cells or primary prostate cancer cells; Berthon et al., 1995; Sramkoski et al., 1999; Maitland et al., 2001) . Furthermore, in screens of clonogenic activity with a range of chemotherapeutic agents and UV irradiation, we have found that, in general, PNT2C2 and P4E6 cells show high sensitivity, 22Rv1 cells show intermediate sensitivity and PC3 and LNCaP cells show high resistance. Thus, in the prostate cancer cell lines examined, endogenous GAS5 transcript levels appear to be inversely correlated with both tumorigenic behavior and responses to cell death-inducing stimuli.
The level of expression of GAS5 in the breast cancer cell lines examined also showed a general inverse correlation with tumorigenic behavior, although, as might be expected, the correlation is not perfect. In the T47D, MCF-7 and Hs578T cell lines, the level of GAS5 transcripts is 10-fold higher than those in MDA-MB-231, the most metastatic cell line capable of producing lung and lymph metastasis in a high proportion in nude mice (Lacroix and Leclercq, 2004) . On the other hand, the expression levels of GAS5 in MCF-10A, the breast cell derived from normal breast cells, were approximately half of those in T47D, MCF-7 and Hs578T cell lines. Our present study shows that whereas MCF-7 is highly sensitive to UV and cisplatin-induced cell death, MCF-10A shows intermediate sensitivity to UV, cisplatin and other death-inducing agents (Figures 3 and 4) .
Human GAS5 is encoded at 1q25, a locus that has been associated with abnormalities in several types of cancer, including melanoma (Smedley et al., 2000) , prostate (Nupponen and Carpten, 2001 ) and breast (Stange et al., 2006; Morrison et al., 2007) . Chromosomal rearrangements involving GAS5 have been reported recently in a human B-cell lymphoma (Nakamura et al., 2008) as well as in radiation-induced murine thymic lymphoma TL10 (Tsuji et al., 2003) . When GAS5 expression levels in breast cancer tissue were compared with those found in untransformed breast epithelial tissue from the same patients, a clear reduction of more than 65% was observed (Figure 8 ). This reduction was statistically significant for both stages I and II cancer, suggesting that the reduction in GAS5 expression is an early event in oncogenesis.
As GAS5 acts to increase, or sensitize to, apoptosis in the breast epithelial cells examined (Figures 3 and 4) , the substantial reduction in breast cancer tissue expression suggests that GAS5 may be acting as a tumor suppressor in these cells. Recent genetic and functional analyses have indicated that the snoRNA U50 is a candidate tumor suppressor (Dong et al., 2008) . U50 is found at a chromosome breakpoint in a human B-cell lymphoma (Tanaka et al., 2000) and, like GAS5, is a member of the 5 0 TOP gene family encoding box C/D snoRNAs within the introns of a gene with no significant protein-coding potential (Tanaka et al., 2000) . U50 overexpression reduced the colony-forming ability of prostate cancer cells and a mutation in U50 was strongly associated with clinically significant prostate cancer. Taken together, these two studies are likely to stimulate investigation of the possible role of these and other snoRNAs in oncogenesis and in resistance to cytotoxic therapy. Such roles may be particularly important in breast and prostate cancers but may also prove to be significant in a broader range of cancers. Cisplatin (no. 155663-27-1) , butyrate (no. B5887), okadaic acid (no. O4511), doxorubicin (no. 25316-40-9) and dexamethasone (no. D4902) were purchased from Sigma (Gillingham, UK). Caspase inhibitors Z-IE(Ome)TD(Ome)-FMK (Cat no. 218759, caspase-8 inhibitor) and Z-LE(OMe)HD(OMe)-FMK (Cat no. 218761, caspase-9 inhibitor) were purchased from CalBiochem (Nottingham, UK).
Materials and methods

Materials
Cell culture
The HEK 293T cell line, the human prostate cell lines PNT2C2, 22Rv1 and LNCaP, and the mouse W7.2 thymoma cell line subclone (W7.2c) were maintained in RPMI-1640 medium (Sigma) supplemented with 10% heat-inactivated fetal calf serum (HyClone, Cramlington, UK), 2 mM L-glutamine and 200 mg/ml gentamicin (Sigma) at 37 1C in a 5% CO 2 humidified incubator. Human prostate PC3 cells were cultured in nutrient mix F-12 (Kaighn's modification) supplemented with fetal bovine serum (10%) and gentamicin (50 mg/ml).
Human prostate P4E6 cells were cultured in keratinocyte serum-free medium supplemented with L-glutamine (2 mM), 5 ng/ml epidermal growth factor, 25 mg/ml bovine pituitary extract, fetal bovine serum (2%) and gentamicin (50 mg/ml). The non-tumorigenic breast epithelial cell line MCF-10A and the human breast cancer cell lines MCF-7, T47D, MDA-MB-231 and Hs578T were maintained in MEM (Eagle's minimum essential medium; Sigma) supplemented with 5% heatinactivated fetal calf serum, 2 mM L-glutamine, 200 mg/ml gentamycin and 10 mg/ml insulin. All experiments were carried out using cells in the logarithmic growth phase.
Determination of cell viability and detection of apoptosis Cell viability was determined by nigrosin blue dye exclusion analysis. Cell proliferation was also determined by using the CellTiter 96 AQ ueous One Solution Cell Proliferation Assay (no. G3582; Promega, Southampton, UK), according to the manufacturer's instructions. The CaspaTag TM Fluorescein Caspase Activity Kit (no. S7300-025; InterGen, Oxford, UK) was used to detect active caspases in the cells as a marker for caspase-dependent apoptosis, according to the manufacturer's instructions. Detection was performed using a fluorescence microscope.
Transfection
As verified by sequence analysis, all cDNAs correspond to GAS5 ESTs. The different GAS5 ESTs (MourtadaMaarabouni et al., 2008) in the expression vector pcMVSPORT6 or the vector alone were introduced into HEK 293T cells using the transfection reagent GeneJammer (no. 204130; Stratagene, Frampton, UK). Efficiency of transfection was 70-80%. MCF-7 and MCF-10A were transfected using the Nucleofector (Amaxa, Cologue, Germany; program P-20, Cologne, Germany) and the nucleofector kit V (Amaxa; no. VCA-1003). Efficiency of transfection was 75-85%. The expression of GAS5 was assessed after 24 h by RT-PCR and by real-time RT-PCR.
UV treatment
A UVG-54 hand-held lamp (UVP) was used for irradiation. The irradiance from the lamps was routinely measured using the J-225 Black-Ray UV (short wave) intensity meter (SER# 44725). Cells (10 6 ) were exposed to UV irradiation in plastic Petri dishes with the lids removed for 20 s at a distance of 25 cm (40 J/m 2 ). After UV exposure, the irradiated medium was replaced by fresh medium.
Clonogenic assay
Long-term survival and proliferation of cells transfected with GAS5 constructs or vector alone were assessed by the ability of the cells to form colonies in soft agar. An equal proportion of culture from each experimental condition was diluted in 5 ml Iscove's medium (Sigma) containing 20% heat-inactivated fetal calf serum, 10% cell-specific conditioned medium and 0.3% Noble agar (Difco, Lawrence, KS, USA) and plated in 60 mm Petri dishes. Agar was overlaid with 2.5 ml Iscove's complete medium containing 10% cell-conditioned medium. The number of colonies formed was counted after 2-3 weeks incubation at 37 1C in 5% CO 2 .
Breast sample collection Paired tumor and adjacent normal breast epithelial tissues were collected from a total of 21 female patients with ductal breast cancer, rapidly frozen and stored at -140 1C.
Semiquantitative and real-time RT-PCR Total RNA was isolated from breast tissue using 1.4 M guanidine thiocyanate/0.5% sodium dodecyl sulfate/25 mM EDTA/50 mM Tris-Cl (pH 7.5) (Chirgwin et al., 1979; Smale and Sasse, 1992) . RNA was isolated from cell lines using TRIZOL reagent (no. 15596-026; GIBCO BRL, Paisley, UK). RNA from W7.2c cells, breast tissue, transfected and untransfected breast cells and prostate cell lines was treated with RQ1 RNase-free DNase (Promega). RNA from all cells and tissues was reverse transcribed using random hexamer priming and SuperScript II Reverse Transcriptase (Invitrogen, Paisley, UK), according to the manufacturers' instructions.
For semiquantitative RT-PCR, cell line cDNA (500 ng) was amplified using GAS5 forward primer located in exon 9 (5 0 -GAAATGCAGGCAGACCTGTTATCC-3 0 ) and GAS5 reverse primer located in exon 12 (5 0 -GACTACCTCAGAGT ACCGTGTTCT-3 0 ). PCR products were subcloned using the TOPO PCR cloning Kit (Invitrogen) and sequenced (MWG Biotech, Ebersberg, Germany).
For W7.2c cells, real-time RT-PCR was carried out using TaqMan Assay ID Mm 00657322; exon boundary 6-7 (Applied Biosystems, Warrington, UK). For all human cell lines and tissues, real-time RT-PCR was performed using TaqMan MGB primers and probe specific for human GAS5 (designed by Applied Biosystems; forward primer: CTTCTGGGCTCAAGTGATCCT; reverse primer: TTGT GCCATGAGACTCCATCAG; probe: CCTCCCAGTG GTCTTT). Note that the assay location is in exon 12 of GAS5, so that it will detect the expression of all GAS5 ESTs used. For all cell lines transfected with pCMVSPORT6 constructs, eukaryotic 18S rRNA served as the endogenous control (Applied Biosystems; assay ID Hs99999901_s1), assays contained 500 ng cDNA and a comparative C T method was employed with pCMVSPORT6-transfected cells as calibrators. A similar approach was used to quantify endogenous GAS5 expression in prostate and breast cell lines, with 22Rv1 and MCF-7 cell lines serving as the respective calibrators. For clinical breast samples, a standard curve, comprising cDNA prepared from the T47D human breast cell line, was included with each assay run to allow relative quantitation. Assays contained 0.1-30 ng standard cDNA (in duplicate) or 5 ng sample cDNA (in triplicate) in a final volume of 25 ml, and ALAS1 (assay code Hs00167441_m1) served as endogenous control. Assays were run on an ABI (Warrington, UK) Prism Sequence Detection System Model 7000, and data analysis was performed using ABI Prism 7000 SDS software. 
Statistical analysis
Data are presented as the mean ± s.e. Statistical significance was determined by analysis of variance. Breast cancer data were analysed either by a paired Student's t-test or by one-way analysis of variance with Bonferroni's multiple comparison test for post hoc analysis of selected groups, depending on the number of groups to be compared. Homogeneity of variance was checked by Bartlett's test and, where necessary, data were log-transformed before analysis.
